National Age-Related Eye Disease Study (AREDS II) Confirms Effectiveness Of Birmingham-Based Macular Health Vision Supplement
BIRMINGHAM, Ala., May 13, 2013 /PRNewswire/ — The results of the second largest ophthalmic study in history were released on May 5, 2013 by the National Eye Institute (NEI) and confirms that Macular Health, LLC, a Birmingham, Ala.,-based company producing ophthalmic nutraceuticals, has had the ideal formulated product to combat Age-Related Macular Degeneration (AMD) since 2003.
Macular Health’s original formulation was modeled after the results of the largest ophthalmic study ever conducted, AREDS I, that was released in 2001. However, John O. Mason, III M.D., a retina surgeon from the University of Alabama at Birmingham (UAB) Callahan Eye Foundation Hospital, modified the AREDS formula in 2003 when he and Macular Health CEO and President Jeffery McAnnally introduced the company’s AMD supplement.
The release of the AREDS II results confirm that the ingredients, lutein and zexanthin effectively replace beta carotene in the AREDS formulation and are key in slowing vision loss due to AMD. Beta carotene is proven to increase the risk of lung cancer in smokers and former smokers. In 2003, Macular Health was the first company to release a Smokers Formula that omitted beta carotene. Competing nutraceutical companies added Omega-3 fatty acids to the original AREDS formula anticipating that the results of AREDS II would find them beneficial. The AREDS II results found the benefit of adding Omega-3 fatty acids to be negligible.
“We are thrilled that the NEI’s AREDS II Study confirmed that the Macular Health eye supplement is truly the best formulation for those afflicted with Age-Related Macular Degeneration,” said McAnnally. “With Age-Related Macular Degeneration serving as the leading cause of blindness in adults and diagnosed every three minutes in the United States, we are proud to offer the most affordable and medically proven product available to slow the advancement of vision loss caused by the condition.”
ABOUT MACULAR HEALTH LLC
President and CEO Jeffery McAnnally developed Macular Health in 2003, with the help of an ophthalmologist who has a family history of Age-Related Macular Degeneration. Today, Macular Health’s products are sold throughout the United States and the company is a leader in the ophthalmic nutraceutical industry. Macular Health, LLC has a dedicated team of employees to provide excellent customer service and the best products for those suffering from Macular Degeneration. For more information, visit www.macularhealth.com.
SOURCE Macular Health